Biracin-E Bidiphar eye drops treat eye infections caused by sensitive strains (5ml)
Dosage form Bottle x 5ml
Specifications Tobramycin
Ingredient Bidiphar
Ingredient
| Composition information | Content |
| Tobramycin | 0.3% |
Uses
Indications
Biracin-E indicated in the treatment of eye infections caused by sensitive strains: eyelid inflammation, conjunctivitis, vaginal inflammation, keratitis.
Pharmacokology
Tobramycin is an aminoglycosid antibiotic obtained from the streptomyces culture environment Tenebrarius. The drug has a bactericidal effect. Although the exact acting mechanism is unknown, perhaps the protein synthesis inhibitors in sensitive bacteria by attaching it is not reversible to the 30S subunit of ribosom.
In In vitro studies show that Tobramycin is a drug against sensitive strains of microorganisms: Staphylococci, including S.Aureus and S. Epidermidis (positive coagulase and negative coagulase), including penicillin strains. Streptococcus, including a number of hemolytic species of group A, some species do not cause hematopopistic, and some streptococcus pneumoniae, Pseudomonas Aeruginosa, Escherichia Coli, Klebsiella Pneumoniae, Enterobacter Aerogenes, Proteus Mirabilis, Morganella Morganiiiiiiiiii Vulgaris, Haemophilus Influenzae and H.AGyptius, Moraxella Laconata, Acinetobacter Calcoaceticus and some Neisseria species. Researching the sensitivity of bacteria proves that in some cases, bacteria resistance to gentamicin are still sensitive to tobramycin.
pharmacokinetics
for eye drops have not yet found the pharmacokinetic properties in documents.
Before taking Biracin-E Bidiphar eye drops treat eye infections caused by sensitive strains (5ml)
How to use
Biracin-E is used in small eyes.
Dosage
For mild and medium infections: small 1-2 drops into the conjunctiva, every 4 hours.
With severe infections: 2 drops into the conjunctiva, every 1 hour. Continue to treat until supporting, then reduce the number of small drugs.
Note: The above dose is for reference only. Specific dosage depends on the condition and level of progression of the disease. For a suitable dose, you need to consult a doctor or medical specialist.
What to do when overdose? If symptoms occur, stop using the drug.
What to do when you forget a dose? However, if close to the next dose, skip the forgotten dose and take the next dose at the time as planned. Note that it should not be used double the prescribed dose.
Side Effects
When using Biracin-E you may experience unwanted effects (ADR).
Uncommon, 1/1000 Hypersensitivity and toxicity at the place of use, including itchy eyelids and swelling, and conjunctiva. Instructions on how to handle ADR When experiencing side effects of the drug, it is necessary to stop using and notify the doctor or go to the nearest medical facility for timely treatment.
Warnings
Before using the drug you need to read the instructions carefully and refer to the information below.
Contraindicated
Biracin-E drugs are contraindicated in the following cases: People with a history of allergies to any component of the drug and with aminoglycoside antibiotics.
Caution when using
as with other antibiotics, long -term use can lead to over -growth of non -sensitive bacteria, including mushrooms. If superinfection occurs, appropriate treatment should be started.
Diagonal allergies to other aminoglycosides can occur. Stop used if there is a sensitive reaction to Tobramycin.
The ability to drive and operate machinery
does not affect the neurological effect when driving and operating machinery.
Pregnancy
There is no adequate and controlled study in pregnant women, should only be used during pregnancy when really necessary.
Breastfeeding period
Tobramycin is secreted into breast milk in small amounts and no problems for breastfed babies are notified.
Drug interaction
There has been no drug interaction in documents.
Storage
Sightseeing, temperature below 30 ° C, avoiding light.
Other drugs
- CEFALEXIN 500MG TABLETS
- ETORICOXIB 90MG TABLETS
- EllaOne
- Grastofil
- LIPANTHYL 200MG MICRONISED CAPSULES
- SEVEN SEAS ONE A DAY PURE COD LIVER OIL CAPS
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions